Trials / Completed
CompletedNCT03563014
A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 164 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this non interventional study is to describe the proportion of Belgian mCRPC patients which were treated with 1 to 4 and 5 to 6 Radium-223 injections and the patient characteristics which are potentially associated with this proportion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Radium-223 (Xofigo, Bay88-8223) | Follow the physician's prescription in routine clinical practice. |
Timeline
- Start date
- 2018-07-31
- Primary completion
- 2019-01-31
- Completion
- 2019-01-31
- First posted
- 2018-06-20
- Last updated
- 2020-05-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03563014. Inclusion in this directory is not an endorsement.